Add-on Acquisition • Life Science

Merck Acquires Schering-Plough

On November 3, 2009, Merck acquired life science company Schering-Plough for 41.1B USD

Acquisition Context
  • This is Merck’s 7th transaction in the Life Science sector.
  • This is Merck’s largest (disclosed) transaction.
  • This is Merck’s 7th transaction in the United States.
  • This is Merck’s 2nd transaction in New Jersey.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free


M&A Deal Summary

Date November 3, 2009
Target Schering-Plough
Sector Life Science
Buyer(s) Merck
Deal Type Add-on Acquisition
Deal Value 41.1B USD

Target Company

Schering-Plough

Kenilworth, New Jersey, United States
Schering-Plough Corp. is a manufacturer and sells pharmaceuticals.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Merck

Rahway, New Jersey, United States

Category Company
Founded 1891
Sector Life Science
Employees70,000
Revenue 64.2B USD (2024)
DESCRIPTION
Merck office in Palo Alto, California.
Merck office in Palo Alto, California.

Merck is a global healthcare company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The Company’s operations are comprised of four operating segments: Pharmaceutical, Animal Health, Consumer Care and Alliances. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices. The Company also has animal health operations that discover, develop, manufacture and market animal health products, including vaccines, which the Company sells to veterinarians, distributors and animal producers. Additionally, the Company has consumer care operations that develop, manufacture and market over-the-counter, foot care and sun care products. Merck was established in 1891 and is based in Rahway, New Jersey.


Deal Context for Buyer #
Overall 8 of 37
Sector: Life Science 7 of 34
Type: Add-on Acquisition 8 of 35
State: New Jersey 2 of 3
Country: United States 7 of 28
Year: 2009 1 of 1
Size (of disclosed) 1 of 29
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-07-30 Merial

Duluth, Georgia, United States

Merial Ltd. is an animal health company, providing a comprehensive range of products to enhance the health, well-being and performance of a wide range of animals.

Sell $4.0B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-12-02 SmartCells

Beverly, Massachusetts, United States

SmartCells, Inc. is focused on developing glucose-regulated SmartInsulin products for the treatment of diabetes mellitus.

Buy $500M